Skip to content
value.today

CoDa Therapeutics Inc

Total raised
$52 M
6 rounds on record
Latest round
$9 M
Dec 2020
First round on record
Apr 2011
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CoDa Therapeutics Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$9 MNo. 6$2 to $10 million

CoDa Therapeutics Inc: Raise no. 6, Dec 2020

Investors in this round

3 investors had bought by the notice of Jan 13, 2021: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Levy · Executive Officer, Director
  • David Pool · Executive Officer
  • James Blair · Director
  • Pavel Rodyukov · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amounts paid pursuant to conversion of indebtedness.”

Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 13, 2021. Read the notice at the SEC.

equitySEC
Jun 2015$1 MNo. 5Under $2 million

CoDa Therapeutics Inc: Raise no. 5, Jun 2015

Investors in this round

2 investors had bought by the notice of Jun 15, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford Duft · Executive Officer, Director
  • David Pool · Executive Officer
  • "Howard ""Ted""" Greene · Director
  • Geoff Brooke · Director
  • Inna Martin Eitan · Director
  • James Blair · Director
  • James Mervis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes estimated amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's preferred stock (assuming no net issue exercise, where applicable). The warrants have not yet been exercised.”

Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 15, 2015. Read the notice at the SEC.

debt, optionsSEC
Feb 2015$1 MNo. 4Under $2 million

CoDa Therapeutics Inc: Raise no. 4, Feb 2015

Investors in this round

2 investors had bought by the notice of Feb 19, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford Duft · Executive Officer, Director
  • David Pool · Executive Officer
  • "Howard ""Ted""" Greene · Director
  • Geoff Brooke · Director
  • James Blair · Director
  • James Mervis · Director
  • Mikhail Getman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes estimated amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's preferred stock (assuming no net issue exercise, where applicable). The warrants have not yet been exercised.”

Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 19, 2015. Read the notice at the SEC.

debt, optionsSEC
May 2014$3 MNo. 3$2 to $10 million

CoDa Therapeutics Inc: Raise no. 3, May 2014

Investors in this round

2 investors had bought by the notice of Jun 10, 2014: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $6 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford Duft · Executive Officer, Director
  • David Pool · Executive Officer
  • "Howard ""Ted""" Greene · Director
  • Anton Gopka · Director
  • Geoff Brooke · Director
  • James Blair · Director
  • James Mervis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes estimated amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's preferred stock (assuming no net issue exercise, where applicable). The warrants have not yet been exercised.”

Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 10, 2014. Read the notice at the SEC.

debt, optionsSEC
Jul 2012$19 MNo. 2$10 to $50 million

CoDa Therapeutics Inc: Raise no. 2, Jul 2012

Investors in this round

1 investor had bought by the notice of Aug 1, 2012: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford Duft · Executive Officer, Director
  • David Pool · Executive Officer
  • "Howard ""Ted""" Greene · Director
  • Anton Gopka · Director
  • Geoff Brooke · Director
  • James Blair · Director
  • James Mervis · Director
  • Peter Thompson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 1, 2012. Read the notice at the SEC.

equitySEC
Apr 2011$19 MNo. 1$10 to $50 million

CoDa Therapeutics Inc: Raise no. 1, Apr 2011

Investors in this round

4 investors had bought by the notice of May 13, 2011: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $35 M offered; $16 M still to sell
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford Duft · Executive Officer, Director
  • David Pool · Executive Officer
  • Colin Green · Director
  • Geoff Brooke · Director
  • Howard Greene, Jr. · Director
  • James Blair · Director
  • James Mervis · Director
  • Peter Thompson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed May 13, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CoDa Therapeutics Inc chose not to state its revenue in its newest notice of a funding round (Jan 2021).

    SEC Form D · Jan 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2021

That is all the official record says: CoDa Therapeutics Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CoDa Therapeutics Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CoDa Therapeutics Inc
NameRoleNamed in
Brian LevyExecutive officerJan 2021
David PoolExecutive officerJan 2021
Bradford DuftExecutive officerJun 2015
Brian LevyDirectorJan 2021
James BlairDirectorJan 2021
Pavel RodyukovDirectorJan 2021
"Howard ""Ted""" GreeneDirectorJun 2015
Bradford DuftDirectorJun 2015
Geoff BrookeDirectorJun 2015
Inna Martin EitanDirectorJun 2015
James MervisDirectorJun 2015
Mikhail GetmanDirectorFeb 2015
Anton GopkaDirectorJun 2014
Peter ThompsonDirectorAug 2012
Colin GreenDirectorMay 2011
Howard Greene, Jr.DirectorMay 2011